Orthopoxviruses (OPXVs) have a broad host range in mammalian cells, but 26
we revealed a species-specific difference in host restriction factor SAMD9L as the cause 28 for the restriction and identified orthopoxvirus CP77 as a unique inhibitor capable of 29
antagonizing Chinese hamster SAMD9L (chSAMD9L). Two known VACV inhibitors of 30 SAMD9 and SAMD9L (SAMD9&L), K1 and C7, can bind human and mouse 31 SAMD9&L, but neither can bind chSAMD9L. CRISPR-Cas9 knockout of chSAMD9L 32 from CHO cells removed the restriction for VACV, while ectopic expression of 33 chSAMD9L imposed the restriction for VACV in a human cell line, demonstrating that 34 chSAMD9L is a potent restriction factor for VACV. Contrary to K1 and C7, cowpox 35 virus CP77 can bind chSAMD9L and rescue VACV replication in cells expressing 36 chSAMD9L, indicating that CP77 is yet another SAMD9L inhibitor but has a unique 37 specificity for chSAMD9L. Binding studies showed that the N-terminal 382 amino acids 38 of CP77 were sufficient for binding chSAMD9L and that both K1 and CP77 target a 39 common internal region of SAMD9L. Growth studies with nearly all OPXV species 40
showed that the ability of OPXVs in antagonizing chSAMD9L correlates with CP77 gene 41 status and that a functional CP77 ortholog was maintained in many OPXVs, including 42 monkeypox virus. Our data suggest that species-specific difference in rodent SAMD9L 43 poses a barrier for cross-species OPXV infection and that OPXVs have evolved three 44 SAMD9L inhibitors with different specificities to overcome this barrier. 45
46

INTRODUCTION 61 62
The orthopoxvirus (OPXV) genus of the poxvirus family consists of more than 63 ten closely-related species, including the infamous human pathogen variola virus (VARV, 64 causative agent for smallpox), the smallpox vaccine vaccinia virus (VACV), and 65 emerging zoonotic agents monkeypox virus (MPXV) and cowpox virus (CPXV) (1). 66
These viruses as well as ectromelia virus (ECTV), camelpox virus (CMLV) and teterapox 67 virus (TATV) are known as the Old World OPXVs for originating from the Eurasian 68 continent, while raccoonpox virus (RNCV), skunkpox virus (SKPV) and volepox virus 69
MATERIALS AND METHODS 116 117
Cells and viruses. VERO (ATCC CCL-81), BSC40 (ATCC CRL-2761), BT20 (ATCC 118
HTB-19), and CHO-K1 (ATCC CCL-61) were originally from ATCC. HEK 293FT was 119 from Thermo Fisher Scientific (cat. no. R70007). WT VACV WR strain, K1L and C7L 120 deletion VACV (vK1 -C7 -) and a panel of vK1 -C7 --derived recombinant viruses 121 expressing VACV-K1 (vVACV-K1L) or a C7 homolog from different poxviruses 122 123 vSPPV-063 and vSWPV-064) were described before (22, 26, 27) . Other OPXVs (28) CP77 with a C-terminal V5 tag, and (iv) ~500 bp of upstream flanking region of CP77 136 including the CP77 promoter. Specific mutations of CP77 were introduced into the 137 plasmid through recombinant PCR as described previously (26 GGATGACGATGACAAGGCAGAGAAACTCAACCTTCCAGAGA-3' and 5'-147 GGCTCCGCGGTTAGACAATTTTAATGTCATAAGCA-3') from cDNA synthesized 148 from CHO cellular mRNAs. A 3xFlag tag sequence was then appended to the 5' end of 149 the ORF by PCR, and the final PCR product was cloned between KpnI and SacII sites of 150 the pcDNA3.1/V5-His-topo vector (Thermo Fisher Scientific). The chSAMD9 cDNA 151 was completely sequenced and found to be identical to the Chinese hamster SAMD9 152 reference sequence in GenBank (XM_016963772.1). chSAMD9L ORF was cloned 153 similarly but with the primer pair (5'-154 TGACGATGACAAGAATGAACAAGTAACTGCACCTAAATTGG-3' and 5'-155 GGCTCCGCGGTTAGATTACTTTTATGCCATATGCCAGAGG-3'). The chSAMD9L 156 cDNA was found to be identical to the Chinese hamster SAMD9L sequence 157 XM_027389843.1 except for a difference at codon 618 (T to C substitution) that did not 158 result in an amino acid change. Plasmids for expressing NTPase-TPR domains of 159 SAMD9&L were constructed similarly but with PCR primers that only amplify the 160 specific region of SAMD9&L. All known poxvirus antagonists of SAMD9&L were able to bind their targets in 221 mammalian cells (25, 37) . To assess whether they could also inhibit SAMD9&L from 222
Chinese hamster, we first set out to study their binding to Chinese hamster SAMD9&L. 223
Chinese hamster SAMD9 (chSAMD9) and SAMD9L (chSAMD9L) were cloned from 224 CHO cells into a mammalian expression vector and transiently expressed in HEK 293FT 225 cells. The cells were then infected with a panel of vK1 -C7 -derived VACV expressing 226 different V5-tagged viral proteins, including one that expressed CPXV CP77 (vCPXV-227 CP77). The ability of the V5-tagged viral protein to bind the Flag-tagged SAMD9 or 228 SAMD9L was assessed by immunoprecipitation (IP) with anti-V5 antibody followed by 229
Western blot. All known poxvirus SAMD9&L antagonists, including K1, C7 and C7 230 homologs from diverse mammalian poxviruses, failed to precipitate chSAMD9L ( Fig.  231 1A), in contrast to the binding of SAMD9&L from human and mouse by nearly all these 232 viral proteins (25, 37). Interestingly, CP77 was able to precipitate chSAMD9L, 233 suggesting that it is also a SAMD9L inhibitor and has a unique specificity for 234 chSAMD9L. All the tested viral proteins except for K1 failed to precipitate chSAMD9 235 (Fig, 1B) . Altogether, SAMD9&L from Chinese hamster stand out among the 236 SAMD9&L that have been characterized so far for their resistance to binding by many of 237 the known poxvirus SAMD9&L inhibitors. vCPXV-CP77, which grew more than 100-fold in titer after 24 h of infection (Fig.  250   2A&B ). In contrast, the two chSAMD9L KO cells (named ∆SAMD9L) were permissive 251 for vK1 -
C7
-as well as all its derivatives (Fig. 2C&D ). Several cell clones were also 252 isolated and found to be similar to the pooled cells in permissiveness for VACV (Fig. 2E) . 253
The specific KO of either chSAMD9 or chSAMD9L in the cell clones were confirmed by 254 sequencing the region targeted by CRISPR-Cas9 guide. Indels that result in frameshift 255 were found (Fig. 2F ). These data show that chSAMD9L but not chSAMD9 is required for 256 restricting VACV replication in CHO cells and that CP77 has a unique capability of 257 antagonizing chSAMD9L. The well-characterized ∆SAMD9L clone 2F was used in all 258 subsequent experiments. 259
It was previously shown that VACV replication in CHO cells was blocked at 260 translation of post-replicative mRNA (18). To assess the effect of SAMD9L KO on viral 261 early and post-replicative protein synthesis, we infected the parental and ∆SAMD9L 262 CHO cells with VACVs that expressed luciferase gene under the control of either the 263 synthetic early/late promoter or the late p11 promoter. In some infections, viral DNA 264 replication was blocked to allow only early protein synthesis. The early luciferase 265 expression measured at 8 hpi was at a comparable level in BSC40 cells and ∆SAMD9L 266 CHO cells but was reduced by 10-fold in the parental CHO cells (Fig. 3A) . A similar 267 reduction on early luciferase expression was also observed at 24 hpi (Fig. 3B) . However, 268 the greatest difference between the parental and ∆SAMD9L CHO cells was observed on 269 post-replicative, late luciferase expression, which was reduced by ~10,000-fold in the 270 parental CHO cells (Fig. 3B) controlled by the tetracycline-dependent promoter. The cell line (named i-chSAMD9L) 280 expressed chSAMD9L only when induced with doxycycline, in a dose-dependent manner 281 (Fig. 4A) . When not induced to express chSAMD9L, i-chSAMD9L cells were fully 282
-(or its derivatives), which grew by ~1000-fold in titer after 24 h 283 of infection (Fig. 4B) . When induced to express chSAMD9L, the cell line became 284 nonpermissive for vK1 -C7 -and its derivatives that either expressed K1 (vVACV-K1) or 285 C7 (vVACV-C7) (Fig. 4B) , recapitulating CHO cells in terms of the restriction of 286 poxvirus. Moreover, vCPXV-CP77 was able to grow ~100-fold in titer after 24 h of 287 infection, again demonstrating that CP77 can antagonize chSAMD9L. 288 289 K1 and CP77 target the same region of SAMD9&L. 290 A computational analysis predicated SAMD9&L having the following domains 291 from the N-to the C-terminus (38): SAM, AlbA, SIR2, P-loop NTPase, TPR, and OB 292 (Fig. 5A) . The N-terminal 385 aa of human SAMD9 (hSAMD9), which contains the 293 predicted SAM and AlbA domains, was reported to be sufficient for binding to a 294 poxvirus C7 homolog (39). To find out which region of hSAMD9 is targeted by K1, we 295 constructed hSAMD9 mutants with deletions in different domains and tested the binding 296 of the mutants to K1. We found aa 607-1172 of hSAMD9, which contains the putative 297
NTPase and TPR domains, was sufficient for binding to K1 but not C7 (Fig. 5B ). This 298 binding was disrupted by two specific K1 substitution mutations (S2C#2 or S1-mut6) that 299 were previously shown to disrupt K1 host-range function in human cells (20) . 300
Furthermore, both K1 and CP77, but not C7, can bind to the similar region of mouse 301 SAMD9L (aa 598-1172), but only CP77 can bind to this region of chSAMD9L (aa 594-302 1172) (Fig. 5B) . Thus, the binding to NTPase-TPR domain by K1 and CP77 displays the 303 same species-specificity as to the full-length protein.
Altogether, the data demonstrate 304 that K1 and CP77 target the same NTPase-TPR region of SAMD9&L, differing from the 305 region that is targeted by C7. 306
307
The N-terminal 382 aa of CP77 is sufficient for binding to chSAMD9L. 308
The full-length CP77 of 668 aa was predicted to contain 9 ankyrin repeats with a 309 C-terminal F-box domain (Fig. 6A) . Only the N-terminal 352 aa was reported to be 310 necessary for the function of CP77 in CHO cells, and the deletion of ankyrin repeat 5 311 could disrupt CP77 function (40). To determine whether chSAMD9L binding has a 312 similar requirement for CP77 residues, we constructed recombinant VACV from vK1 expressing the full-length CP77 (Fig. 6B) . In contrast, the virus expressing a CP77 with a 317 deletion in aa 235-266 (the predicted ankyrin repeat 5, ∆5) failed to grow in CHO cells. 318
Correspondingly, CP77-∆C can precipitate both the full-length and the NTPase-TPR 319 region of chSAMD9L, whereas CP77-∆5 cannot precipitate either (Fig. 6C) . A reduced 320 amount of full-length chSAMD9L was precipitated by CP77-∆c than by full-length CP77, 321 correlating with the reduced growth in CHO cells by the CP77-∆c-expressing VACV. 322
Compared to the full-length CP77, CP77-∆C was also detected at a reduced level in the 323 infected cells (Fig. 6C) . 324
325
The ability of OPXV in antagonizing chSAMD9L corresponds to their CP77 gene 326
status. 327
CP77 gene is variably maintained and diversified in different OPXV species 328 (Table 1) . To assess the ability of chSAMD9L in restricting different OPXV species, we 329 compared the growth of all available OPXV species in the parental and ∆SAMD9L CHO 330 cells (Fig. 7) . ECTV and CMLV are similar to VACV for growing in ∆SAMD9L CHO 331 cells but failing to grow in the parental CHO cells, indicating that chSAMD9L is also a 332 restriction factor for ECTV and CMLV. The CMLV CP77 ortholog is largely deleted 333 with only ~155 nucleotides left, while the ECTV CP77 ortholog has a large deletion at 334 the 5' end that results in an early frameshift. On the other hand, MPXV, TATV, AKMV, 335 SKPV, and VPXV grew in both the parental and ∆SAMD9L CHO cells with nearly the 336 same efficiency, indicating that chSAMD9L did not pose significant restriction for their 337 replication. These OPXV species all encode a full-length CP77 ortholog, with the two 338 North American OPXVs (SKPV and VPXV) having the most divergent ortholog of 339 ~70% aa identity to CPXV CP77. RCNV, another North American OPXV, also grew in 340 both the parental and ∆SAMD9L CHO cells, but the yield was more than 10-fold less in 341 the parental cells at both 24 and 48 h post infection (Fig. 7) , indicating that chSAMD9L 342 shown some species-specific difference in susceptibility to poxvirus inhibitors (25, 44, 358 45) . In this study, we revealed a species-specific difference in SAMD9L as the cause for 359 the restriction of several OPXVs (VACV, ECTV, CMLV) in a rodent cell, suggesting 360 that divergence in SAMD9L (and perhaps SAMD9) in rodent species presents a major 361 barrier for cross-species poxvirus infection. Furthermore, we identified CP77 as the third 362 OPXV SAMD9L inhibitor with a unique species specificity, demonstrating the 363 sophistication brought forth by OPXVs to antagonize SAMD9&L. 364
OPXVs have broad host range in tissue culture cells, but CHO cells, while 365 permissive for CPXV (16), are nonpermissive for VACV (14) and ECTV (46). What 366 host factor causes the restriction of some OPXV species in CHO cells had been enigmatic 367 since the initial discovery more than 50 years ago (14) . In this study, we solved this 368 mystery by identifying chSAMD9L as the host restriction factor in CHO cells. We 369 presented two complementary lines of evidence: 1) CRISPR-Cas9 KO of chSAMD9L 370 from CHO cells completely removed the host restriction for VACV, ECTV and CMLV; 2) 371 ectopic expression of chSAMD9L in a human cell line recapitulated the poxvirus 372 restriction property of CHO cells. We also provided a molecular explanation why 373 chSAMD9L could restrict some OPXV species, namely its resistance to binding by both 374 K1 and C7, the two SAMD9&L inhibitors in these OPXV species. Interestingly, while 375 SAMD9 is the constitutive poxvirus restriction factor in many human cells (23) (24) (25) , 376 chSAMD9 appears not to contribute to poxvirus restriction in CHO cells. KO of 377 chSAMD9L alone is sufficient for abolishing the restriction of a panel of VACVs, most 378 of which did not contain K1, the only protein that was shown to bind chSAMD9. 379
Moreover, KO of chSAMD9 had no effect on poxvirus restriction in CHO cells. CHO 380 cells thus resemble mouse cells more than human cells in that SAMD9L is the 381 constitutive restriction factor (25). It is unclear why chSAMD9 does not restrict 382 poxviruses in CHO cells. We speculate that either chSAMD9 has lost the antiviral 383 function due to some lineage-specific mutations or chSAMD9 expression level in CHO 384 cells is not sufficiently high. The former scenario would be analogous to the fate of 385 mouse SAMD9, which had suffered a mouse lineage-specific gene loss (47). The latter 386 scenario would be similar to human SAMD9L, which has to be induced to a high 387 expression level by IFN to impose restriction on vK1 WT or mutated CP77. Viral growth was determined as described in Fig. 2 . 503 (C). Full-length and aa 594-1172 of chSAMD9L were subjected to co-504 immunoprecipitation with either WT or mutated CP77 as described in Fig. 1 . 
